OMDA
Omada Health, Inc.
NASDAQ · Healthcare · Medical - Healthcare Information Services · US
$20.43
+3.03%Next report
Analyst consensus
- Next report date
- Nov 5, 2026
- EPS estimate
- $0.09
- Revenue estimate
- $85.4M
Latest reported
- Last report date
- Aug 6, 2026
- EPS actual
- $0.15
- EPS estimate
- $0.06
- Revenue actual
- $87.8M
- Revenue estimate
- $80.0M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 5
- EPS misses (12Q)
- 0
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +437.4%
- Revenue beats (12Q)
- 4
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $30
- PT range
- $25 – $35
- Analysts
- 9
8 Buy1 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 6, 2026 | $0.06 | $0.15 | Beat 141.16% | $87.8M |
| May 7, 2026 | -$0.13 | -$0.05 | Beat 60.78% | $78.0M |
| Mar 5, 2026 | $0.01 | $0.13 | Beat 1427.61% | $75.8M |
| Nov 6, 2025 | -$0.10 | $0.02 | Beat 120.00% | $68.0M |
| Aug 7, 2025 | -$0.10 | -$0.09 | Beat 10.00% | $61.4M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 5, 2026